| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 12,000 | $44.09 | $529,080.00 | -1.3% | +32.3% | +105.6% | |
| Jun 1, 2022 | Grossi Federico53 | Chief Medical Officer | Sell | 2,500 | $41.78 | $104,450.00 | -2.2% | +42.3% | +111.1% | |
| May 27, 2022 | Scheibler Lukas54 | Chief Innovation Officer | Sell | 10,000 | $43.00 | $430,000.00 | -19.9% | +39.2% | +104.1% | |
| May 16, 2022 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $39.18 | $48,975.00 | -0.5% | +76.7% | +125.7% | |
| May 2, 2022 | Grossi Federico53 | Chief Medical Officer | Sell | 2,500 | $43.56 | $108,900.00 | -2.2% | +24.0% | +84.9% | |
| Apr 29, 2022 | Deschatelets Pascal69 | Chief Scientific Officer | Sale+OE | 4,000 | $44.43 | $177,720.00 | -0.4% | +31.6% | +91.7% | |
| Apr 25, 2022 | Watson David O.70 | General Counsel | Sell | 5,000 | $50.00 | $250,000.00 | -3.8% | +10.0% | +77.0% | |
| Apr 20, 2022 | Delong Mark Jeffrey76 | Senior Vice President | Sale+OE | 7,000 | $52.53 | $367,710.00 | -19.7% | -1.5% | +55.9% | |
| Apr 14, 2022 | MacHiels Alec57 | Director | Sale+OE | 1,250 | $50.90 | $63,625.00 | -0.5% | -9.1% | +53.3% | |
| Apr 5, 2022 | Scheibler Lukas54 | Chief Innovation Officer | Sale+OE | 609 | $60.09 | $36,592.98 | -1.2% | -18.9% | +30.6% |